Centene's stock plunge offers a potential long-term opportunity. Click here for a full investment analysis of CNC stock.

This conjecture is not overly bullish as well, as similarly observed in UNH's ongoing recovery from the May 2025 P/E bottom ...

Centene shares plummeted Wednesday after the managed-care company withdrew its full-year outlook after receiving new data ...

The MarketBeat consensus price target on Centene is nearly $69, implying 107% upside from the stock’s June 3 closing price.

Shares of health insurance provider Elevance Health (NYSE:EVH) fell 11.5% in the afternoon session after the company reported ...

Morgan Stanley initiated coverage with an Overweight rating and a $70 price target, highlighting Centene’s growth opportunities in the Medicaid and Medicare markets.

Shares of health coverage company Centene (NYSE:CNC) fell 39.4% in the afternoon session after the company unexpectedly withdrew its full-year 2025 financial guidance, citing significantly higher-than ...

The firm reiterated its Buy rating and $73.00 price target on Centene stock despite the guidance withdrawal. Centene’s previous 2025 adjusted EPS guidance was "greater than" $7.25 per share, but the ...

This drop followed the company’s announcement of disappointing Q1 results, the later retraction of its earnings forecast, and ...

Centene Corp shares fell 25% in after-market trading on Tuesday after the health insurer withdrew its 2025 earnings guidance ...

Shares of health insurance company Oscar Health (NYSE:OSCR) fell 5% in the afternoon session after Wells Fargo downgraded the ...

Centene (CNC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ...